Lung cancer alters the hydrolysis of nucleotides and nucleosides in platelets - 07/02/12
Corresponding author. Tel.: +55-55-3220-9557; fax: +55 55 32208978.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 6 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Background |
The nucleotides and nucleosides of adenine are signaling molecules related to thromboregulation and modulation of immune responses in patients with malignancies. Thus, this study aims to determine NTPDase, 5′-nucleotidase, ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in the platelets of patients with lung cancer.
Methods |
We collected blood samples from patients (n=33) previously treated for lung cancer with chemotherapy. Patients were classified as stage IIIb and IV according to the Union for International Cancer Control (UICC).
Results |
Patients showed a significant decrease in the hydrolysis of adenosine diphosphate (ADP) and adenosine, whereas the adenosine monophosphate (AMP) hydrolysis and platelet aggregation were significantly increased in this group. Adenosine triphosphate (ATP) hydrolysis did not show significant results between the group of patients and the control group.
Conclusions |
We may suggest that ectonucleotidases as well as ADA are enzymes involved in thromboembolic events but especially here we may see that they are also directly involved in the generation of adenosine formation in the cancer patient circulation.
Le texte complet de cet article est disponible en PDF.Keywords : Lung neoplasm, NTPDase, Ectonucleotide pyrophosphatase/phosphodiesterase, 5′-nucleotidase, Adenosine deaminase
Plan
Vol 66 - N° 1
P. 40-45 - février 2012 Retour au numéro
Article précédent
- Oral ACTH (H.P. Acthar®Gel) inhibits IL-1 and IL-17 secretion in humans
- Staley A. Brod, Victoria Bauer, Zachary Hood
- N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: Preparation, characterization, and pharmacokinetics
- Guowei Qu, Xiaoli Wu, Lifang Yin, Can Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?